Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Latagliata, Roberto; Cristiano, Gianluca; Lama, Dorela; Fenu, Susanna; Rizzo, Lorenzo; Cambò, Benedetta; Zoletto, Simone; Spirito, Francesca; Cavalca, Fabrizio; Cattaneo, Daniele; Cenfra, Natalia; Luca, Giulia De; Vangone, Beatrice Esposito; Palmieri, Raffaele; Annunziata, Mario; Mulas, Olga; Abruzzese, Elisabetta; Molteni, Alfredo; Piedimonte, Monica; Carmosino, Ida; Salutari, Prassede; Biagi, Annalisa; Bocchia, Monica; Santopietro, Michelina; Binotto, Gianni; Iurlo, Alessandra; Crugnola, Monica; Riva, Marta; Piccioni, Anna Lina; Elli, Elena Maria; Curti, Antonio; Poloni, Antonella

doi:10.1182/blood-2022-167334

Blood

2022

DOI: 10.1182/blood-2022-167334

|View full text |Cite

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata

Gianluca Cristiano

Dorela Lama

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?

Solana-Altabella,

Rodríguez-Veiga,

Martínez-Cuadrón

et al. 2024

Ann Hematol

View full text Add to dashboard Cite

A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?

Solana-Altabella,

Rodríguez-Veiga,

Martínez-Cuadrón

et al. 2024

Ann Hematol

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Cited by 1 publication

References 0 publications

A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?

A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?

Contact Info

Product

Resources

About